

Harbor Health Secures $130M To Grow Insurance Plans and Clinical Footprint
Harbor Health's funding was co-led by General Catalyst, 8VC and Alta Partners. The round also includes participation from Dell Family Office Management, Health 2047 Capital Partners, Lemhi Ventures, Martin Ventures and Breyer Capital.

With Drug Picked Up From Sanofi, Startup AllRock Takes Aim at Two Severe Lung Diseases
AllRock Bio’s drug is a small molecule pan-ROCK inhibitor ready for Phase 2 testing in pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease. The startup is led by the management team that steered CinCor Pharma to a $1.3 billion acquisition by AstraZeneca.

Humans Make the Game: What Baseball’s Tech Debate Can Teach Healthcare About the Value of Connection
Healthcare, like baseball, is ultimately a human experience. And no matter how advanced the tools, patients still want to feel something real: that someone sees them, hears them, and cares.